Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,281.0
3.0 (0.09%)

 

  • STI Straits Times Index
    3,281.0
    3.0 (0.09%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,595.8
    7.9 (0.50%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    29,056.4
    173.4 (0.60%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,075.5
    1.4 (0.05%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    24,041.3
    108.1 (0.45%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    6,291.7
    5.6 (0.09%)
    Index delayed 10 minutes
  • KOR KOSPI
    2,250.6
    2.5 (0.11%)
    Index delayed 20 minutes
  • XAO XAO
    7,180.3
    21.7 (0.30%)
     

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 1,723.5M
  • Value: 1,021.1M
  • Rise: 204
  • Fall: 116
  • Unch: 499

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
AsiaPhos0.047+0.019
Golden Agri-Res0.235-
OEL0.029+0.009
Sincap0.013+0.003
Rex Intl0.192+0.011
AusGroup^0.048+0.001
BlackGoldNatural0.018+0.002
AsiaMedic0.013+0.002
Ley Choon0.022+0.004
GCCP0.009+0.002

World Indices

World Indices
Name Last Change
Nasdaq 9,388.9 +31.8
HSI 29,056.4 +173.4
HSCEI 11,419.9 +91.5
Jakarta 6,291.7 +5.6
Nikkei 225 24,041.3 +108.1
SSE Comp 3,075.5 +1.4
Shanghai A 3,222.5 +1.4
Shanghai B 260.1 +2.0
PSE Comp 0.0
KOSPI 2,250.6 +2.5

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

IMPEDIMED LIMITED IMPEDIMED
Updated on 17 Jan 2020 (End of trading day)
Last (AUD): 0.160 Change: -0.010 High: 0.165 Remarks: -
Change (%): -5.88 Low: 0.160
Open 0.160 Yesterday's Close 0.17
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 384,921 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (AUD) a -0.04720 Trailing EPS (AUD) e -0.04720 NAV (AUD) b 0.0309
PE a - Trailing PE f - Price / NAV b 5.1780
Dividend (AUD) d - Cash In Hand (AUD) g 0.0222 Issued & Paid-up Shares c 511,049,000
Dividend Yield (%) d - Price / Cash In Hand g 7.207 Treasury Shares h -
Beta - 75 Daysi 1.236 R-Squared - 75 Days(%)i 2.83 Market Cap (M) 81.768
Beta - 500 Daysi 1.324 R-Squared - 500 Days (%)i 2.67 Enterprise Value (M) 70.438
Piotroski F Score 2 Exchange Code IPD Par Value ( AUD ) n.a.
52 Weeks Volatility (%) 85.60 Free Float (%) 91.3
Sector & Industry Health Technology - Medical Specialties
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 08 Jan 2020.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 16 Jul 2015.
  9. Beta and R-Squared are calculated in relation to the market index using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference IMPEDIMED LIMITED ASX 81.768 - - 5.1780 -
Industry Medical Specialties ASX 1,514.944 56.703 57.191 9.0394 1.127
Local Peer COCHLEAR LTD ASX 13,920.235 50.308 50.308 19.1766 1.368
Local Peer FISHER & PAYKEL HEALTHCARE CORP ASX 12,363.399 63.301 56.107 14.4749 1.185
Local Peer EBOS GROUP ASX 3,817.997 27.727 27.727 3.0732 2.965
Local Peer NANOSONICS LIMITED ASX 2,127.370 156.395 156.401 19.3231 -
Local Peer MEDICAL DEVELOPMENT INTL ASX 609.492 587.231 587.179 13.6698 0.430
Local Peer MCP INCOME OPPORTUNITIES TRUST ASX 606.045 - - -424.4898 -
Local Peer VOLPARA HEALTH TECHNOLOGIES LTD ASX 406.083 - - 7.0271 -
Local Peer SOMNOMED LIMITED ASX 172.712 - - 9.6933 -
Local Peer COMPUMEDICS ASX 124.900 31.098 31.101 4.5720 -
Local Peer RESONANCE HEALTH LTD ASX 112.030 88.136 88.196 18.9781 -
Local Peer ELLEX MEDICAL LASERS LTD ASX 107.701 - - 1.5654 -
Local Peer SDI LTD ASX 105.196 14.353 14.353 1.4393 4.181
Other Local Peers CYCLOPHARM LIMITED (ASX), ADMEDUS LTD (ASX), OVENTUS MEDICAL LTD (ASX), EMVISION MEDICAL DEVICES LTD (ASX), IMPRESSION HEALTHCARE LIMITED (ASX), RESPIRI LTD (ASX), MICRO-X LTD (ASX), LBT INNOVATIONS LTD (ASX), UNIVERSAL BIOSENSORS INC NPV (CDI) (ASX), OBJ LIMITED (ASX), DIMERIX LTD (ASX), CARDIEX LTD (ASX), USCOM LTD (ASX), ALLEGRA ORTHOPAEDICS LIMITED (ASX), OPTISCAN IMAGING (ASX), IMAGION BIOSYSTEMS LIMITED (ASX), OSPREY MEDICAL INC NPV (CHESS DEPOSITARY INTERESTS) (ASX), ANALYTICA (ASX), ADHERIUM LIMITED (ASX), METALICITY LIMITED (ASX), MEDIGARD LIMITED (ASX), NEUROTECH INTERNATIONAL LTD (ASX)
Global Peer MEDTRONIC PLC NYSE 159,545.431 34.452 34.171 3.1544 1.748
Global Peer ABBOTT LABORATORIES NYSE 157,298.600 66.850 48.089 4.9438 1.295
Global Peer THERMO FISHER SCIENTIFIC INC NYSE 136,012.137 46.294 37.865 4.6334 0.216
Global Peer DANAHER CORP NYSE 117,122.900 44.182 48.177 3.7901 0.383
Global Peer STRYKER CORP NYSE 79,436.448 22.358 23.186 6.4504 0.910
Global Peer BECTON DICKINSON & CO NYSE 74,939.057 - - - -
Global Peer INTUITIVE SURGICAL INC NASDAQ 69,347.867 61.484 52.772 8.9350 -
Global Peer BOSTON SCIENTIFIC CORP NYSE 61,718.350 36.935 56.622 6.3633 -
Global Peer EDWARDS LIFESCIENCES CORP NYSE 49,773.145 68.919 64.331 13.0474 -
Global Peer BAXTER INTERNATIONAL INC NYSE 45,812.190 28.209 28.958 5.8643 0.817
Other Global Peers ZIMMER BIOMET HOLDINGS INC (NYSE), IDEXX LABORATORIES INC (NASDAQ), RESMED INC (NYSE), ALIGN TECHNOLOGY INC (NASDAQ), SMITH & NEPHEW ADR EACH REPR 2 ORD (NYSE), DEXCOM INC (NASDAQ), METTLER-TOLEDO INTERNATIONAL INC (NYSE), TELEFLEX INC (NYSE), COOPER COS INC (NYSE), WATERS CORP (NYSE), GENMAB AS SPON ADS EACH REP 0.1 ORD SHS (NASDAQ), HOLOGIC INC (NASDAQ), VARIAN MEDICAL SYSTEMS INC (NYSE), DENTSPLY SIRONA INC (NASDAQ), STERIS PLC (NYSE), INSULET CORPORATION (NASDAQ), WEST PHARMACEUTICAL SERVICES INC (NYSE), BIO RAD LABORATORIES INC (NYSE), PERKINELMER INC (NYSE), NOVOCURE LTD (NASDAQ), MASIMO CORPORATION (NASDAQ), BRUKER CORPORATION (NASDAQ), ABIOMED INC (NASDAQ), QIAGEN NV (NYSE), HILL-ROM HOLDINGS INC (NYSE), WEIGAO GROUP (HKEx), HAEMONETICS CORP (NYSE), PENUMBRA INC (NYSE), GLOBUS MED INC (NYSE), ENVISTA HOLDINGS CORPORATION (NYSE), INTEGRA LIFESCIENCES HLDGS CORP (NASDAQ), HARTA (Bursa), NUVASIVE INC (NASDAQ), TANDEM DIABETES CARE INC (NASDAQ), ICU MEDICAL INC (NASDAQ), WRIGHT MEDICAL GROUP NV (NASDAQ), NEOGEN CORP (NASDAQ), NEVRO CORP (NYSE), LIVANOVA PLC (NASDAQ), CONMED CORP (NASDAQ), QUIDEL CORP (NASDAQ), TOPGLOV (Bursa), Top Glove (SGX), CANTEL MEDICAL CORP (NYSE), GLAUKOS CORPORATION (NYSE), IRHYTHM TECHNOLOGIES INC (NASDAQ), MERIT MEDICAL SYSTEMS (NASDAQ), MICROPORT (HKEx), INSPIRE MEDICAL SYSTEMS INC (NYSE), STAAR SURGICAL CO (NASDAQ), CARDIOVASCULAR SYSTEMS INC DEL (NASDAQ), BIOTELEMETRY INC (NASDAQ), AK MEDICAL (HKEx), AVANOS MEDICAL INC (NYSE), ATRICURE INC (NASDAQ), INMODE LTD (NASDAQ), SHOCKWAVE MEDICAL INC (NASDAQ), SILK ROAD MEDICAL INC (NASDAQ), ATRION CORP (NASDAQ), VAREX IMAGING CORPORATION (NASDAQ), NATUS MEDICAL INC (NASDAQ), MESA LABORATORIES INC (NASDAQ), TACTILE SYSTEMS TECHNOLOGY INC (NASDAQ), CRYOLIFE INC (NYSE), INOGEN INC (NASDAQ), AXONICS MODULATION TECHNLOGS INC (NASDAQ), VENUS MEDTECH-B (HKEx), CAREDX INC (NASDAQ), ACCELERATE DIAGNOSTICS INC (NASDAQ), CIRC (HKEx), ORTHOFIX MEDICAL INC (NASDAQ), LIFETECH SCI (HKEx), HESKA CORP (NASDAQ), ORTHOPEDIATRICS CORP (NASDAQ), VERICEL CORP (NASDAQ), LANTHEUS HOLDINGS INC (NASDAQ), LEMAITRE VASCULAR INC (NASDAQ), ANTARES PHARMA INC (NASDAQ), QUOTIENT LTD (NASDAQ), ANGIODYNAMICS INC (NASDAQ), CERUS CORP (NASDAQ), AXOGEN INC (NASDAQ), ESTABLISHMENT LABS HLDGS INC (NASDAQ), SURMODICS INC (NASDAQ), SI BONE INC (NASDAQ), ORASURE TECHNOLOGIES INC (NASDAQ), CUTERA INC (NASDAQ), VIEWRAY INC (NASDAQ), ALPHATEC HLDGS INC (NASDAQ), YESTAR HEALTH (HKEx), OXFORD IMMUNOTEC GLOBAL PLC (NASDAQ), SUPERMX (Bursa), TRANSMEDICS GROUP INC (NASDAQ), CORMEDIX INC (NYSE American), SEASPINE HOLDINGS CORP (NASDAQ), INFUSYSTEM HOLDINGS INC (NYSE American), UTAH MEDICAL PRODUCTS (NASDAQ), SIENTRA INC (NASDAQ), ZYNEX INC (NASDAQ), STEREOTAXIS INC (NYSE American), BIOLIFE SOLUTIONS INC (NASDAQ), INOVIO PHARMACEUTICALS INC (NASDAQ), RTI SURGICAL HOLDINGS INC (NASDAQ), MISONIX INC (NASDAQ), IRADIMED CORP (NASDAQ), INVACARE CORP (NYSE), FLUIDIGM CORP DEL (NASDAQ), GOLDEN MEDITECH (HKEx), PULSE BIOSCIENCES INC (NASDAQ), ACCURAY INCORPORATED (NASDAQ), PW MEDTECH (HKEx), AVADEL PHARMACEUTICALS PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), GENMARK DIAGNOSTICS INC (NASDAQ), APYX MEDICAL CORPORATION (NASDAQ), VAPOTHERM INC (NYSE), KDL MEDICAL (HKEx), SOLITON INC (NASDAQ), REPRO MEDSYSTEMS INC (NASDAQ), NYMOX PHARMACEUTICALS CORP(BAHAMAS) (NASDAQ), MODERN DENTAL (HKEx), ITAMAR MEDICAL LTD SPON ADS EACH REP 30 ORD SHS (NASDAQ), VENUS CONCEPT INC (NASDAQ), TELA BIO INC (NASDAQ), INTRICOM CORP (NASDAQ), ROCKWELL MEDICAL INC (NASDAQ), PROFOUND MED CORP (NASDAQ), CYTOSORBENTS CORP (NASDAQ), FONAR CORP (NASDAQ), DERMTECH INC (NASDAQ), BRAINSWAY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), MY MEDICARE (HKEx), SOLENO THERAPEUTICS INC (NASDAQ), BIOSIG TECHNOLOGIES INC (NASDAQ), YUNNAN ENERGY (HKEx), ONCOCYTE CORP (NYSE American), ENLIVEX THERAPEUTICS LTD (NASDAQ), CONFORMIS INC (NASDAQ), MRI INTERVENTIONS INC (NASDAQ), NEURONETICS INC (NASDAQ), SECOND SIGHT MEDICAL PRODUCTS INC (NASDAQ), ELECTROMED INC (NYSE American), NEMAURA MEDICAL INC (NASDAQ), NEPHROS INC (NASDAQ), STRATA SKIN SCIENCES INC (NASDAQ), SENSUS HEALTHCARE INC (NASDAQ), CHEMBIO DIAGNOSTICS INC (NASDAQ), HELIUS MEDICAL TECHNOLOGIES INC (NASDAQ), MOTUS GI HOLDINGS INC (NASDAQ), KELFRED (HKEx), COLLPLANT BIOTECHNOLOGIES LTD SPON ADS EACH REP 1 ORD SHS (NASDAQ), APOLLO ENDOSURGERY INC (NASDAQ), PAVMED INC (NASDAQ), MILESTONE SCIENTIFIC INC (NYSE American), ALPHA PRO TECH (NYSE American), RETRACTABLE TECHNOLOGIES INC (NYSE American), VINCENT MED (HKEx), IRIDEX CORP (NASDAQ), Biolidics (SGX), ELECTROCORE INC (NASDAQ), DAXOR CORP (NYSE American), CELSION CORPORATION (NASDAQ), ENDOLOGIX INC (NASDAQ), IMMUCELL CORP (NASDAQ), Yunnan Energy (SGX), EKSO BIONICS HOLDINGS INC (NASDAQ), ZOSANO PHARMA CORP (NASDAQ), BIOMERICA INC (NASDAQ), NEOVASC INC (NASDAQ), XTANT MEDICAL HLDGS INC (NYSE American), BELLEROPHON THERAPEUTICS INC (NASDAQ), LIFE HEALTHCARE (HKEx), TRINITY BIOTECH PLC ADR EACH REPR 4 CLS A ORD USD0.019 (NASDAQ), NANOVIBRONIX INC (NASDAQ), BIOLASE INC (NASDAQ), ADVENTA (Bursa), RA MEDICAL SYSTEMS INC (NYSE), Medtecs Intl (SGX), TITAN MEDICAL INC (NASDAQ), UG Healthcare (SGX), DARIOHEALTH CORP (NASDAQ), LKL (Bursa), CHECK-CAP LTD (NASDAQ), NEUROTROPE INC (NASDAQ), REWALK ROBOTICS LTD (NASDAQ), CYANOTECH CORP (NASDAQ), OBALON THERAPEUTICS INC (NASDAQ), ATOSSA THERAPEUTICS INC (NASDAQ), PREDICTIVE ONCOLOGY INC (NASDAQ), THERMOGENESIS HOLDINGS INC (NASDAQ), Annica (SGX), COMBEST HOLD (HKEx), AVINGER INC (NASDAQ), HANCOCK JAFFE LABORATORIES INC (NASDAQ), INSPIREMD INC (NYSE American), LIANLUO SMART LIMITED (NASDAQ), TENAX THERAPEUTICS INC (NASDAQ), DYNATRONICS CORP (NASDAQ), HUAKANG BIOMED (HKEx), MEDIGUS SPON ADS EACH REP 50 ORD SHS (POST SPLT) (NASDAQ), MICRON SOLUTIONS INC (NYSE American), AETHLON MEDICAL INC (NASDAQ), VALERITAS HOLDINGS INC (NASDAQ), ALLIED HEALTHCARE PRODUCTS INC (NASDAQ), DIGIRAD CORP (NASDAQ), STHAI (SET), CHF SOLUTIONS INC (NASDAQ), CH DEMETER FIN (HKEx), NEUROMETRIX INC (NASDAQ), VIVEVE MEDICAL INC (NASDAQ), SINTX TECHNOLOGIES INC (NASDAQ), AKERS BIOSCIENCES INC (NASDAQ)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days --0.005
-3.03 %
10 Days -+0.005
+3.23 %
20 Days --0.020
-11.11 %
Medium Term Return 3 Months ---
6 Months -+0.010
+6.67 %
1 Year --0.038
-19.19 %
Long Term Return 2 Years --0.770
-82.80 %
3 Years --0.641
-80.02 %
5 Years --0.636
-79.90 %
Annualised Return Annualised --
-27.45 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 0.104 - 0.341 Change From 1 Year Low +0.056 % Change From 1 Year Low (%) +53.99
Change From 1 Year High -0.181 % Change From 1 Year High (%) -53.12
2 Years Range 0.104 - 0.950 Change From 2 Years Low +0.056 % Change From 2 Years Low (%) +53.99
Change From 2 Years High -0.790 % Change From 2 Years High (%) -83.15
5 Years Range 0.104 - 1.800 Change From 5 Years Low +0.056 % Change From 5 Years Low (%) +53.99
Change From 5 Years High -1.640 % Change From 5 Years High (%) -91.11
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

ImpediMed Ltd. engages in the development and distribution of bioimpedance devices with a focus on medical applications in the fluid status area. It operates through the Medical, and Test and Measurement segments. The Medical segment supplies non-invasive medical technology products and services to measure, monitor, and manage tissue composition and fluid status using bioimpedance spectroscopy. The Test and Measurement segment offers power precision testing and measuring equipment. The company was founded by Melvyn John Bridges and Lucille Mayse Bridges on September 27, 1999 and is headquartered in Pinkenba, Australia.

Historical Price Data

Date Open High Low Close Volume VWAP
17 Jan 2020 0.160 0.165 0.160 0.160 384,921 -
16 Jan 2020 0.170 0.170 0.160 0.170 253,679 -
15 Jan 2020 0.160 0.170 0.160 0.170 229,578 -
14 Jan 2020 0.165 0.175 0.160 0.175 229,611 -
13 Jan 2020 0.165 0.175 0.162 0.175 274,684 -
10 Jan 2020 0.160 0.165 0.155 0.165 264,442 -
09 Jan 2020 0.160 0.160 0.155 0.155 553,923 -
08 Jan 2020 0.155 0.160 0.150 0.160 211,380 -
07 Jan 2020 0.160 0.160 0.155 0.155 635,415 -
06 Jan 2020 0.155 0.160 0.150 0.160 570,224 -
03 Jan 2020 0.160 0.160 0.155 0.155 166,000 -
02 Jan 2020 0.160 0.160 0.155 0.155 1,046,237 -
31 Dec 2019 0.170 0.170 0.165 0.165 164,839 -
30 Dec 2019 0.165 0.170 0.165 0.165 494,526 -
27 Dec 2019 0.170 0.175 0.165 0.170 189,184 -
24 Dec 2019 0.170 0.180 0.165 0.180 125,086 -
23 Dec 2019 0.175 0.175 0.160 0.170 898,107 -
20 Dec 2019 0.175 0.185 0.175 0.180 111,260 -
19 Dec 2019 0.175 0.185 0.175 0.185 83,395 -
18 Dec 2019 0.175 0.180 0.175 0.175 131,871 -
17 Dec 2019 0.180 0.185 0.175 0.185 168,897 -
16 Dec 2019 0.185 0.185 0.177 0.185 163,046 -
Summary
Current 2 Weeks
(06 Jan 2020 to 17 Jan 2020)
0.155 0.175 0.150 0.160 3,607,857 -
Previous 2 Weeks
(18 Dec 2019 to 03 Jan 2020)
0.175 0.180 0.150 0.155 3,410,505 -
4 Weeks from
(20 Nov 2019 to 17 Dec 2019)
0.200 0.200 0.150 0.185 16,145,664 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.